BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35686228)

  • 41. Distinct genotypic distribution of cytomegalovirus (CMV) envelope glycoprotein B (gB) in a Cuban cohort of patients with different CMV diseases.
    Kourí V; González EE; Martínez PA; Capó V; González R; Pérez L; Viera J; Cardellá L; Hengge UR
    Scand J Infect Dis; 2007; 39(11-12):1038-44. PubMed ID: 17852954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients.
    Toyoda M; Carlos JB; Galera OA; Galfayan K; Zhang X; Sun Z; Czer LS; Jordan SC
    Transplantation; 1997 Apr; 63(7):957-63. PubMed ID: 9112347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytomegalovirus DNAemia detected with real-time polymerase chain reaction in hematopoietic stem cell transplant patients.
    Sahin DG; Gunduz E; Kasifoglu N; Akay OM; Us T; Gulbas Z
    Adv Ther; 2013 Aug; 30(8):784-91. PubMed ID: 23959787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytomegalovirus Glycoprotein B Genotype in Patients with Anterior Segment Infection.
    Huang CY; Cheng YC; Hwang YS; Kang EY; Hsiao CH
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Similar reduction of cytomegalovirus DNA load by oral valganciclovir and intravenous ganciclovir on pre-emptive therapy after renal and renal-pancreas transplantation.
    Kalpoe JS; Schippers EF; Eling Y; Sijpkens YW; de Fijter JW; Kroes AC
    Antivir Ther; 2005; 10(1):119-23. PubMed ID: 15751769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy.
    Brennan DC; Garlock KA; Lippmann BA; Buller RS; Gaudreault-Keener M; Lowell JA; Miller SB; Shenoy S; Howard TK; Storch GA
    J Am Soc Nephrol; 1997 Jan; 8(1):118-25. PubMed ID: 9013456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CMV gB genotypes and outcome of vertical transmission: study on dried blood spots of congenitally infected babies.
    Barbi M; Binda S; Caroppo S; Primache V; Didò P; Guidotti P; Corbetta C; Melotti D
    J Clin Virol; 2001 Apr; 21(1):75-9. PubMed ID: 11255100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of cytomegalovirus disease by real-time quantitative PCR targeting immediate early gene (ppUL83) in different samples among post-renal-transplant recipients.
    Barani R; Seshan V; Ravi Y; Soundararajan P; Palani G; Srikanth P
    Indian J Med Microbiol; 2019; 37(2):281-284. PubMed ID: 31745032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis, gB genotype distribution and viral load of symptomatic congenitally infected CMV patients in Cuba.
    Correa C; Kourí V; Pérez L; Soto Y; Limia C
    J Perinatol; 2016 Oct; 36(10):837-42. PubMed ID: 27309627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Viral shedding, and distribution of cytomegalovirus glycoprotein H (UL75), glycoprotein B (UL55), and glycoprotein N (UL73) genotypes in congenital cytomegalovirus infection.
    Puhakka L; Pati S; Lappalainen M; Lönnqvist T; Niemensivu R; Lindahl P; Nieminen T; Seuri R; Nupponen I; Boppana S; Saxen H
    J Clin Virol; 2020 Apr; 125():104287. PubMed ID: 32086150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytomegalovirus infection in high-risk kidney transplant recipients receiving thymoglobulin induction-a single-center experience.
    Puttarajappa C; Bhattarai M; Mour G; Shen C; Sood P; Mehta R; Shah N; Tevar AD; Humar A; Wu C; Hariharan S
    Clin Transplant; 2016 Sep; 30(9):1159-64. PubMed ID: 27423138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
    Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
    Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human cytomegalovirus UL55, UL144, and US28 genotype distribution in infants infected congenitally or postnatally.
    Paradowska E; Studzińska M; Suski P; Kasztelewicz B; Wiśniewska-Ligier M; Zawilińska B; Gaj Z; Nowakowska D
    J Med Virol; 2015 Oct; 87(10):1737-48. PubMed ID: 25926093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monitoring of cytomegalovirus infection in solid-organ transplant recipients by an ultrasensitive plasma PCR assay.
    Hadaya K; Wunderli W; Deffernez C; Martin PY; Mentha G; Binet I; Perrin L; Kaiser L
    J Clin Microbiol; 2003 Aug; 41(8):3757-64. PubMed ID: 12904387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes.
    Ishibashi K; Tokumoto T; Tanabe K; Shirakawa H; Hashimoto K; Kushida N; Yanagida T; Inoue N; Yamaguchi O; Toma H; Suzutani T
    Clin Infect Dis; 2007 Jul; 45(1):60-7. PubMed ID: 17554702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of cytomegalovirus DNA in plasma as an adjunct diagnostic for gastrointestinal tract disease in kidney and liver transplant recipients.
    Durand CM; Marr KA; Arnold CA; Tang L; Durand DJ; Avery RK; Valsamakis A; Neofytos D
    Clin Infect Dis; 2013 Dec; 57(11):1550-9. PubMed ID: 23956167
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytomegalovirus infection in renal transplant recipients diagnosed by nested-PCR.
    Aquino VH; Figueiredo LT
    Braz J Med Biol Res; 2001 Jan; 34(1):93-101. PubMed ID: 11151033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipients.
    Boillat Blanco N; Pascual M; Venetz JP; Nseir G; Meylan PR; Manuel O
    Transplantation; 2011 Jan; 91(2):251-5. PubMed ID: 21099744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of glycoprotein B genotypes and load of CMV infecting blood leukocytes on prognosis of AIDS patients.
    Cunha AA; Aquino VH; Mariguela V; Nogueira ML; Figueiredo LT
    Rev Inst Med Trop Sao Paulo; 2011; 53(2):82-8. PubMed ID: 21537755
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
    Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
    BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.